DK304483D0 - Praeparat til anvendelse ved diagnose af infektioner med chlamydia - Google Patents

Praeparat til anvendelse ved diagnose af infektioner med chlamydia

Info

Publication number
DK304483D0
DK304483D0 DK3044/83A DK304483A DK304483D0 DK 304483 D0 DK304483 D0 DK 304483D0 DK 3044/83 A DK3044/83 A DK 3044/83A DK 304483 A DK304483 A DK 304483A DK 304483 D0 DK304483 D0 DK 304483D0
Authority
DK
Denmark
Prior art keywords
chlamydial
preparations
infections
diagnosis
chlamydia
Prior art date
Application number
DK3044/83A
Other languages
English (en)
Other versions
DK304483A (da
Inventor
Pirjo Helena Maekelae
Maija Kaarina Leinonen
Marjatta Nurminen-Kalliokoski
Pekka Auvo Ilmari Saikku
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of DK304483D0 publication Critical patent/DK304483D0/da
Publication of DK304483A publication Critical patent/DK304483A/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56927Chlamydia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50Lipopolysaccharides; LPS
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/879Salmonella
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/823Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK304483A 1982-07-02 1983-07-01 Praeparat til anvendelse ved diagnose af infektioner med chlamydia DK304483A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI822348A FI69639C (fi) 1982-07-02 1982-07-02 Preparat foer anvaendning vid klamydia-diagnostik

Publications (2)

Publication Number Publication Date
DK304483D0 true DK304483D0 (da) 1983-07-01
DK304483A DK304483A (da) 1984-01-03

Family

ID=8515769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK304483A DK304483A (da) 1982-07-02 1983-07-01 Praeparat til anvendelse ved diagnose af infektioner med chlamydia

Country Status (10)

Country Link
US (1) US4652518A (da)
EP (1) EP0098557B1 (da)
JP (1) JPS5927261A (da)
AT (1) ATE27739T1 (da)
AU (1) AU1649283A (da)
CA (1) CA1230551A (da)
DE (2) DE3372018D1 (da)
DK (1) DK304483A (da)
FI (1) FI69639C (da)
NO (1) NO832407L (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818817A (en) * 1983-11-30 1989-04-04 Petroleum Fermentations N.V. Enzymatic degradation of lipopolysaccharide bioemulsifiers
CA1212051A (en) * 1984-03-02 1986-09-30 John W. Cherwonogrodzky Identification of brucella abortus and brucellosis infection
GB8416841D0 (en) * 1984-07-03 1984-08-08 Technology Licence Co Ltd Monoclonal antibodies
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
GB8427006D0 (en) * 1984-10-25 1984-11-28 Iq Bio Ltd Determination of chlamydia trachomatis
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ES2009366A6 (es) * 1986-04-24 1989-09-16 Univ California Procedimiento de obtencion de anticuerpos monoclonales para bacterias gram-negativas.
CA1336576C (en) * 1986-09-26 1995-08-08 National Research Council Of Canada Immunoassays for discriminating between brucellosis infections and vaccinations
DE3875857D1 (de) * 1987-08-13 1992-12-17 Synbiotics Corp Bestimmungen einer amphipathischen substanz durch verwendung einer lipophilen oberflaeche.
US4916057A (en) * 1988-02-29 1990-04-10 Kallestad Diagnostics, Inc. Chlamydia assay employing base treatment
FR2631125A1 (fr) * 1988-05-06 1989-11-10 Pasteur Institut Procede de detection directe de chlamydiae, anticorps monoclonaux anti-chlamydiae et leurs applications au diagnostic des infections chlamydiales
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5484706A (en) * 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents
AU660268B3 (en) * 1993-07-16 1995-06-15 Deakin University Bacteria-specific lipopolysaccharide-like molecules
US5773234A (en) * 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
RU2136001C1 (ru) * 1996-09-17 1999-08-27 Уральский научно-исследовательский институт дермато-венерологии и иммунопатологии Способ иммунодиагностики хламидийной инфекции человека
JPH10339731A (ja) * 1997-06-06 1998-12-22 Mitsubishi Chem Corp 腸管出血性大腸菌感染の検出方法
US7220596B2 (en) * 1998-04-15 2007-05-22 Utah State University Real time detection of antigens
AU754077B2 (en) 1998-04-15 2002-11-07 Utah State University Real time detection of antigens
KR101151202B1 (ko) 2006-10-12 2012-06-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 수중유 에멀젼 애주번트를 포함하는 백신
US9452209B2 (en) * 2007-04-20 2016-09-27 Glaxosmithkline Biologicals Sa Influenza vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039657A (en) * 1975-06-19 1977-08-02 Merck & Co., Inc. Separating antigen from residual common sensitizing protein
US4118469A (en) * 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
US4096035A (en) * 1977-06-15 1978-06-20 Merck & Co., Inc. Separation of trachoma agent from growth medium impurities
GB2047889A (en) * 1979-04-02 1980-12-03 Research Corp Detection of antibodies to chlormydia trachomatis having an immunofluorescence test
EP0017460A1 (en) * 1979-04-02 1980-10-15 Research Corporation Immunofluorescent test method and substance for use therein
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4271146A (en) * 1979-09-06 1981-06-02 Seawell Albert C Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases
US4267170A (en) * 1979-09-06 1981-05-12 Seawell Albert C Methods of using chlamydia vaccine for preventing and treating bovine diseases
IL63907A0 (en) * 1980-09-24 1981-12-31 Cetus Corp Diagnostic method and antibody probe for use therein
US4397959A (en) * 1980-11-05 1983-08-09 Research Corporation Forced precipitation method for preparing antigen/antibody particles
US4497899A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Chlamydia trachomatis antigens

Also Published As

Publication number Publication date
EP0098557B1 (en) 1987-06-10
EP0098557A3 (en) 1984-04-04
DE98557T1 (de) 1984-07-05
FI822348L (fi) 1984-01-03
US4652518A (en) 1987-03-24
JPS5927261A (ja) 1984-02-13
CA1230551A (en) 1987-12-22
FI822348A0 (fi) 1982-07-02
DK304483A (da) 1984-01-03
DE3372018D1 (en) 1987-07-16
EP0098557A2 (en) 1984-01-18
FI69639B (fi) 1985-11-29
FI69639C (fi) 1986-03-10
NO832407L (no) 1984-01-03
AU1649283A (en) 1984-01-05
ATE27739T1 (de) 1987-06-15
JPH0450531B2 (da) 1992-08-14

Similar Documents

Publication Publication Date Title
DK304483A (da) Praeparat til anvendelse ved diagnose af infektioner med chlamydia
Lüderitz et al. Lipopolysaccharides of gram-negative bacteria
Echeverria et al. Case-control study of endemic diarrheal disease in Thai children
Hagberg et al. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections
Udhayakumar et al. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice
Johns et al. Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants
Halter et al. Lipooligosaccharides from Treponema hyodysenteriae and Treponema innocens
Rönnberg et al. Rapid detection by a coagglutination test of heat-labile enterotoxin in cell lysates from blood agar-grown Escherichia coli
Mittal et al. Quantitation of serotype-specific and cross-reacting group-specific antigens by coagglutination and immunodiffusion tests for differentiating Actinobacillus (Haemophilus) pleuropneumoniae strains belonging to cross-reacting serotypes 3, 6, and 8
Aasen et al. Antigenic studies on Staphylococcus epidermidis
Hurvell Serological cross-reactions between different Brucella species and Yersinia Enterocolitica immunodiffusion and immunoelectrophoresis
Tamura et al. Edwardsiella tarda serotyping scheme for international use
ATE87216T1 (de) Polyvalentes hyperimmunglobulin-praeparat.
Holmberg et al. Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia
Montes-García et al. Identification of a hemagglutinin from Gallibacterium anatis
LaBrec et al. Serological identification of Shigella flexneri by means of fluorescent antibody
Dunn et al. Monoclonal antibodies protect against lethal effects of gram-negative bacterial sepsis.
Nowicki et al. Fractionation of a bacterial cell population by adsorption to erythrocytes and yeast cells
Rimler Coagglutination test for identification of Pasteurella multocida associated with hemorrhagic septicemia
Bada et al. Biochemical and antigenic relationships between porcine and equine isolates of Actinobacillus suis
Jones Jr et al. Fluorescent antibody techniques with mycobacteria
M. æland et al. IMMUNOCHEMICAL INVESTIGATIONS ON NEISSERIA GONORRHOEAE ENDOTOXIN: 1. Characterization of Phenol‐Water Extracted Endotoxin and Comparison with Aqueous Ether Preparations
Gruenewald et al. Identification of Salmonella somatic and flagellar antigens by modified serological methods
Saphra et al. Serological relationship amongst Salmonella and other Enterobacteriaceae
Dowdle et al. A phage-fluorescent antiphage staining system for Bacillus anthracis